TXG
10x Genomics, Inc.
Health Information Services · Healthcare · United States
58.15
close · 2026-08-13
value
7
cheaper than peers7
quality
26
stronger fundamentals26
ranked against
Healthcare
value
quality
374 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| price to book | 9.21× | 23 |
| price to sales | 12.05× | 21 |
| forward P/E | 285.99× | 2 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 9.5% | 71 |
| return on equity | -9.4% | 53 |
| operating margin | -15.2% | 24 |
| revenue growth | -12.7% | 10 |
4 of 4 measures available
Facts
| market cap | $8B |
| free cash flow | $179.7M |
| employees | 1,178 |
| first trade | 2019-09-12 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-10 |